WASHINGTON — Senators grilled FDA Commissioner Robert Califf Wednesday on everything from the agency’s stance on a Texas court’s attempt to ban the abortion pill mifepristone to the uptick in clinical trial holds for cell and gene therapies.
Califf has been making the rounds on Capitol Hill to discuss President Biden’s budget request for the Food and Drug Administration, and the appearances give lawmakers a chance to buttonhole him on budget items as well as politically explosive issues that have nothing to do with the funding request.
Cell and gene therapies: Sen. Susan Collins (R-Maine) said the FDA is putting holds on clinical trials of promising therapies without explanation.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect